Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study
Abstract Background Prokineticin 1 (PROK1) was reported as an angiogenic factor, which is associated with tumor progression, cell invasion, and metastasis in colorectal cancer. Although the association between PROK1 expression in primary cancer lesion and patient prognosis was reported, it is unclea...
Main Authors: | Noriyuki Tagai, Takanori Goi, Michiaki Shimada, Hidetaka Kurebayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-021-02421-0 |
Similar Items
-
The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes
by: Roberta Lattanzi, et al.
Published: (2021-03-01) -
Anti-Prokineticin1 Suppresses Liver Metastatic Tumors in a Mouse Model of Colorectal Cancer with Liver Metastasis
by: Hiroko Kono, et al.
Published: (2023-12-01) -
Identification and Characterization of a New Splicing Variant of Prokineticin 2
by: Roberta Lattanzi, et al.
Published: (2022-02-01) -
Interaction of Prokineticin Receptors with Accessory Proteins
by: Roberta Lattanzi, et al.
Published: (2023-11-01) -
Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation
by: Roberta Lattanzi, et al.
Published: (2021-11-01)